Deborah A. Zygmunt - Concepedia

Author

Deborah A. Zygmunt

The Ohio State University

Also Known As

D. Zygmunt, Deborah A. Zygmunt, Deborah Zygmunt, Dobrowolski Zygmunt

Publications

375

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Nationwide Children's Hospital NewPath Research

About

Deborah A. Zygmunt is an author at The Ohio State University specializing in medicine, pathology, and developmental biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	104
2	Allergy	1	1	35
3	Cell Biology	1	1	45
4	Cellular Physiology	1	1	45
5	Immunology	1	1	35

Deborah A. Zygmunt

Publications

350

Citations

H-Index

Page 1

	Year	Citations
Altered MicroRNA Processing in Heritable Pulmonary Arterial Hypertension Kylie M. Drake, Deborah A. Zygmunt, Lori Mavrakis, American Journal of Respiratory and Critical Care Medicine	2011	108
Par-1 kinase establishes cell polarity and functions in Notch signaling in the<i>Drosophila</i>embryo Jennifer L. Bayraktar, Deborah A. Zygmunt, Richard W. Carthew Journal of Cell Science Developmental BiologySignal TransductionSignaling PathwayDrosophila DevelopmentDevelopmental Genetics	2006	45
rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart Rui Xu, Ying Jia, Deborah A. Zygmunt, Molecular Therapy	2019	36
Comparison of Serum rAAV Serotype-Specific Antibodies in Patients with Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Inclusion Body Myositis, or GNE Myopathy Deborah A. Zygmunt, Kelly E. Crowe, Kevin M. Flanigan, Human Gene Therapy Raav SerotypesImmunologyBecker Muscular DystrophyPathologyRaav Serotype	2017	35
A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2 Kevin M. Flanigan, Tatyana A. Vetter, Tabatha R. Simmons, Molecular Therapy — Methods & Clinical Development	2022	31
Expansion of B4GALT7 linkeropathy phenotype to include perinatal lethal skeletal dysplasia Theresa Mihalic Mosher, Deborah A. Zygmunt, Daniel C. Koboldt, European Journal of Human Genetics Developmental AnomalyB4galt7 Linkeropathy PhenotypeDevelopmental BiologyMendelian DisorderGenetic Disorder	2019	24
rAAVrh74.MCK.GALGT2 Demonstrates Safety and Widespread Muscle Glycosylation after Intravenous Delivery in C57BL/6J Mice Deborah A. Zygmunt, Rui Xu, Ying Jia, Molecular Therapy — Methods & Clinical Development	2019	19
An Isolated Limb Infusion Method Allows for Broad Distribution of rAAVrh74.MCK.GALGT2 to Leg Skeletal Muscles in the Rhesus Macaque Rui Xu, Ying Jia, Deborah A. Zygmunt, Molecular Therapy — Methods & Clinical Development	2018	15
Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength Paul T. Martin, Deborah A. Zygmunt, Anna Ashbrook, PLoS ONE	2021	14
Deletion of <i>Pofut1</i> in Mouse Skeletal Myofibers Induces Muscle Aging-Related Phenotypes in <i>cis</i> and in <i>trans</i> Deborah A. Zygmunt, Neha Singhal, Mi-Lyang Kim, Molecular and Cellular Biology	2017	13

Page 1